So there’s this way in which the investment is extremely woven into the American economy. And even if you are not thinking that you are investing in the AI boom, if you are in index funds, if you are ...

Quantumzyme Corp. (OTCQB: QTZM), a global leader in computational enzyme engineering and digital biocatalysis, today announced the expansion of its proprietary AI-powered enzyme design platform to ...

What seems certain is that space and low-orbit laboratories will become an integral tool for drug innovation within the ...

Creating revolutionary pharmaceutical drugs, testing new materials for cars and simulating how market scenarios can affect banks — these are just some of the tasks that could take months or years to ...

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS ...

Welcome to our new monthly video series called What's Trending Online. At the healthcare packaging site, there are 6 articles ...

Building responsible AI is only half the story. Stakeholders need clear visibility into how responsibly the system is ...

E-methanol entered a transformative new phase in 2025 as the first commercial-scale plants came online and global demand from ...

USA: Expected to reach USD 60.5 million by 2025 with a 5.8% CAGR through 2035. A robust generic drug market, advanced R&D ...

The Accreditation Council for Medical Affairs (ACMA) is raising the bar for excellence in life sciences by incorporating artificial intelligence training into its flagship certification, The Board ...

According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...

Swiss drugmaker Novartis opens new manufacturing facility, part of operations expansion in the U.S. that will also invest ...